Alzheimer’s disease is neurodegenerative disorder which causes a progressive dementia that currently affects over 35.6 million individuals worldwide and it is expected that it will be more than triple by 2050…
Read more »
Generation of highly Reactive Oxygen Species (ROS) is an integral feature of a normal cell. Of late, knowledge of free radicals and ROS has brought about a revolution in the domain of health and disease…
Read more »
Case Western Reserve Researchers Discover FDA-approved Drug Rapidly Clears Amyloid from the Brain and Reverses Cognitive and Memory Defects.
Read more »
Increased daily physical activity is associated with a reduction in the risk of Alzheimer’s disease (AD), found a recent cohort study published in the journal Neurology. “Physical activity can be easily done by all elderly or people at risk of AD. It is inexpensive and does not lead to any…
Read more »
Key Point: Donepezil’s cardiac safety profile appears promising in this small-scale, short-term study. If drugs with a similar mechanism of action that affect acetylcholine are prescribed in patients receiving this therapy, patients should be closely monitored for potential cardiac effects. However, these effects have not been significantly demonstrated in patients…
Read more »
indicates a Peer-Reviewed Article
Rheumatoid Arthritis Was Negatively Associated with Alzheimer’s Disease: A Population-Based Case-Control Study
Rheumatoid arthritis is a prevalent autoimmune disease which primarily affects synovial joints. This disease is characterized by progressive joint damage and bone destruction and can…
Read more »